Articles from March 2021
![viewpoint_molecular.jpg viewpoint_molecular.jpg](/sites/iowajpec.org/files/styles/widescreen__1024_x_576/public/2022-04/images/profiles/viewpoint_molecular.jpg?h=0d270b21&itok=qIBJSVcq)
Viewpoint Molecular Targeting sets sights on growth in 2021
Monday, March 8, 2021
Viewpoint Molecular Targeting, an Iowa JPEC Faculty Innovators alumnus, is starting 2021 with momentum. Over the last 6 months, the company accrued $18 million in funding, secured its own supply chain of radioisotopes, unveiled positive preclinical data; and secured its first investigational new drug application by the US FDA in the lead up to their first human trials at the Mayo Clinic and the...